Samay secures an NSF SBIR Phase IIb

Samay has been awarded a $500K SBIR Phase IIb grant from the National Science Foundation to advance their AI-based lung acoustic resonance analysis for mobile monitoring of COPD patients.

With this new grant, Samay’s total funding reaches $4.9 million, with a remarkable 53% of that amount being non-dilutive capital - including the NSF being their largest federal supporter, investing nearly $2 million in Samay to date.

Next
Next

SirenOpt Raises 6.6M